Arobella Medical, LLC Sustainability Profile
Arobella Medical, LLC, headquartered in the United States, is a pioneering company in the medical device industry, specialising in innovative solutions for wound care and surgical applications. Founded in 2015, Arobella has quickly established itself as a leader in the field, with a commitment to enhancing patient outcomes through advanced technology. The company’s core offerings include a range of proprietary wound care products that utilise cutting-edge materials and design, setting them apart from traditional solutions. Arobella's dedication to research and development has led to significant advancements, earning recognition for their unique approach to healing and recovery. With a strong presence in major operational regions across North America, Arobella Medical continues to drive innovation and excellence in healthcare, solidifying its position as a trusted name in the medical community.
DitchCarbon Score
How does Arobella Medical, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Arobella Medical, LLC's score of 18 is lower than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Arobella Medical, LLC's reported carbon emissions
Arobella Medical, LLC, headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Arobella Medical may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives at this time. As the company operates within a sector increasingly focused on sustainability, it may benefit from developing clear climate commitments and reduction strategies to align with broader industry trends and expectations.
How Carbon Intensive is Arobella Medical, LLC's Industry?
How Carbon Intensive is Arobella Medical, LLC's Location?
Arobella Medical, LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Arobella Medical, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
